Curve Biosciences: Funding, Investors & Team (Oct 2026)
Curve Biosciences specializes in precision medicine for chronic diseases, led by a team of experts like Nathan Hunkapiller, PhD, and Chuba Oyolu, PhD. They are at the forefront of biotechnology research, focusing on developing targeted solutions for chronic diseases and emphasizing the importance of precision in treatment. The company is dedicated to improving patient outcomes through innovative research in the biotechnology industry.
Curve Biosciences has raised $57.7M across 2 funding rounds on record, the most recent a Series A of $40.0M announced in Oct 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Curve Biosciences Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Curve Biosciences Funding Rounds
Curve Biosciences raised $17.7M in an undisclosed round announced in May 2024.
1.4 years later, a Series A of $40.0M was announced in Oct 2025.
Curve Biosciences Founders and Leadership Team
Contact details for the Curve Biosciences team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Curve Biosciences Funding Compared to Other Biotechnology Startups
Curve Biosciences' latest round of $40.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Curve Biosciences in Biotechnology and Mountain View
Companies Similar to Curve Biosciences
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Curve Biosciences Funding FAQs
What does Curve Biosciences do?
Curve Biosciences specializes in precision medicine for chronic diseases, led by a team of experts like Nathan Hunkapiller, PhD, and Chuba Oyolu, PhD. They are at the forefront of biotechnology research, focusing on developing targeted solutions for chronic diseases and emphasizing the importance of precision in treatment. The company is dedicated to improving patient outcomes through innovative research in the biotechnology industry.
How much funding has Curve Biosciences raised?
Curve Biosciences has raised $57.7M across 2 rounds on record. The most recent is a Series A of $40.0M announced in Oct 2025.
When did Curve Biosciences last raise funding?
Curve Biosciences' most recent funding round on record is a Series A of $40.0M, announced in Oct 2025.
Who founded Curve Biosciences?
FundedIQ lists Chuba Oyolu (Founder) at Curve Biosciences.
Who is the CEO of Curve Biosciences?
Ritish Patnaik is listed as CEO at Curve Biosciences.
Where is Curve Biosciences headquartered?
Curve Biosciences is based in Mountain View, California, United States.
How many employees does Curve Biosciences have?
Curve Biosciences is in the 1-10 employee band.
How does Curve Biosciences' funding compare to other Biotechnology startups?
Curve Biosciences' latest round of $40.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Curve Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Curve Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.